Anzeige
Mehr »
Login
Sonntag, 19.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
GOLD-MINEN vor Jahrhundert-Hausse?! Diese Aktie sofort kaufen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
33 Leser
Artikel bewerten:
(0)

Bridgetech Gains Access to Financial and Scientific Markets in Europe via Retention of MCC Global as Financial Advisor


SAN DIEGO, May 21 /PRNewswire-FirstCall/ -- Bridgetech Holdings International Inc. (BULLETIN BOARD: BGTH) , a company focused on maximizing the potential of emerging healthcare products and services in the U.S. and Asian markets, today announced that it has retained the services of MCC Global NV, a global strategic consulting and private equity firm with offices worldwide. The relationship provides Bridgetech with significant access to additional financial and scientific resources in Europe.

"Bridgetech is quickly establishing itself as the medical technology transfer leader in China, especially in the field of oncology," stated Michael Chermak, Chairman and CEO of Bridgetech. "We have been focused on executing our long-term plans to increase our global visibility in the market." He added, "By retaining the services of MCC Global, our ability to increase current and potential shareholder awareness of Bridgetech's value is significantly enhanced. This allows us simultaneously gain access to European capital and science."

Anthony Moore, Chairman of MCC Global's Supervisory Board, said "MCC Global is delighted to have the opportunity to work with an exciting growth company headed by an experienced management team. We are particularly interested in exposing Bridgetech to the German and UK marketplaces to draw interests from the respective investment communities, as well as emerging healthcare companies that want to benefit from Bridgetech's unique China platform."


About Bridgetech Holdings International, Inc.

Bridgetech is leveraging its extensive network of relationships in China and the U.S. to capitalize on the demand for Western healthcare in Greater China. The company is bringing emerging drugs, devices and diagnostics to Greater China, with an initial focus on oncology. For additional information, please visit Bridgetech at http://www.bthi.com/.

About MCC Global

MCC Global NV is a global private equity merchant bank specializing in providing strategic and financial advisory an investment services to emerging companies in specific industry sectors such as healthcare, energy renewables, media, real estate, hospitality and lifestyles and fashion and beauty. MCC Global NV (http://www.mccglobal.com/) is listed on the Frankfurt Stock Exchange Geregelter Markt, ticker IFQ2. For additional company information please contact Dana Smith at (801) 816-2500.

Forward-Looking Statements

Statements contained in this press release that are not statements of historical fact are "forward-looking statements" as that term is defined under federal securities laws, including, without limitation, all statements concerning expectations, beliefs, goals, intention or strategies for the future of Bridgetech. Forward-looking statements may be identified by words such as "goals," "plans," "believes," "will," "expects" and other words of similar meaning used in conjunction with, among other things, discussions of future operations, financial performance, product development and new ventures. Many factors could cause actual events or results to differ materially from those expressed in any forward-looking statement. Investors are cautioned not to place any undue reliance on any forward-looking statements.

Contacts: Media Relations: Vince Heald, Beck Ellman Heald - 858-453-9600vheald@behmedia.comInvestor Relations: Redwood Consultants, LLC - 415-884-0348 MCC Global Investor Relations: Dana Smith - 801-816-2500

KI-Champions: 3 Top-Werte, die Ihr Portfolio revolutionieren
Fordern Sie jetzt den brandneuen kostenfreien Sonderreport an und erfahren Sie, wie Sie von den enormen Wachstumschancen im Bereich Künstliche Intelligenz profitieren können - 100 % kostenlos.
Hier klicken
© 2007 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.